- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 112,120 | 05.08.24 19:50:48 | -3,080 | -2,67% | 112,120 | 112,150 | 114,950 | 115,200 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 96,885 | 05.08.24 19:45:37 | -3,305 | -3,30% | 96,520 | 97,380 | 101,010 | 100,190 |
